An in vitro study showed that TMEM59 expression affects Golgi localised complex glycosylation, reducing galactosylation and sialylation of key AD related proteins such as APP, BACE1 and nicastrin using western blot analysis. This evidence concerns the gene APP and Alzheimer disease.